Ghana FDA Medical Device Registry: Classifications, Importers & Countries
A comprehensive, data-driven analysis of the Ghana Food and Drugs Authority (FDA) medical device registry. Explore risk classifications, local agents, and manufacturing origins.
Executive Summary
What does the Ghana Food and Drugs Authority (FDA) products register reveal about registered medical devices, risk classifications, leading local agents, and source countries?
Ghana's FDA medical device products register contains 267 active records. Lower-risk Class I (non-invasive/low-risk) devices represent the majority of listings, with 148 registrations (55.43%), followed by Class II with 92 registrations (34.46%), Class III with 17 (6.37%), and Class IV with 10 (3.75%). China is the leading country of origin with 131 registrations (49.06%), followed by India with 40 (14.98%) and the United Kingdom with 26 (9.74%). The leading local agent is Mokat Chemists Limited with 24 registrations (acting as the representative for UK-based Fortuna Healthcare), followed by Costless Ventures with 21. Registrations peaked in 2025 with 190 approvals, following 76 in 2024 and 1 in 2026.
Introduction to the Ghanaian Medical Device Market
Ghana represents one of the most stable and rapidly expanding economies in West Africa, with a population of approximately 34 million. The Ghanaian government has prioritized healthcare infrastructure expansion, establishing the National Health Insurance Scheme (NHIS) to increase healthcare accessibility and launching hospital construction programs such as "Agenda 111" to build district hospitals across the country.
The Ghanaian medical device and diagnostics market relies almost entirely on foreign imports, with more than 95% of clinical devices, hospital consumables, and laboratory diagnostics sourced globally. This makes Ghana a highly attractive target market for international medtech exporters. However, commercializing products in Ghana requires strict compliance with national regulatory registration gateways.
The importation, registration, and post-market safety of medical devices and in vitro diagnostics (IVDs) in Ghana are governed by the Food and Drugs Authority (FDA), Ghana. Operating under the mandate of the Public Health Act, 2012 (Act 851), the Ghana FDA is responsible for regulating food, drugs, herbal medicines, cosmetics, medical devices, household chemical substances, and clinical trials.
To assist medtech regulatory affairs managers and regional business development teams in navigating this market, MedDeviceGuide has performed a comprehensive, database-level analysis of the official Ghana FDA products register. Based on the latest registry extract from the FDA's VerifyPermit public database portal dated June 22, 2026, this analysis breaks down the registry by risk classifications, maps local agent concentration, identifies leading exporter nations, and traces approval trends to provide actionable regulatory intelligence for market access.
For a broader understanding of global audit frameworks that can streamline entry into Ghana, see our comprehensive MDSAP audit guide. To compare Ghana's regulatory structure with neighboring Nigeria, refer to our Nigeria NAFDAC registry analysis.
The Ghana FDA Regulatory and Legal Framework
The Food and Drugs Authority (FDA) of Ghana enforces medical device compliance under Part Seven of the Public Health Act, 2012 (Act 851). Under this law, no medical device can be manufactured, imported, exported, distributed, advertised, sold, or used in Ghana unless it has been formally registered by the Authority.
The Role of the Local Representative (Local Agent)
To register a medical device in Ghana, a foreign manufacturer must legally appoint a local entity to act as their Local Representative (Applicant / Local Agent). The local agent must be a registered Ghanaian corporate body that possesses an FDA-issued Medical Device Facility License (either as an importer, wholesaler, or distributor). The local representative submits the application, coordinates communication with FDA evaluators, handles local sample testing, and holds the registration license.
Risk-Based Classification
Ghana FDA utilizes a risk-based classification system aligned with the Global Harmonization Task Force (GHTF) and International Medical Device Regulators Forum (IMDRF) frameworks:
- Class I (Low Risk): Non-invasive devices and basic clinical consumables (such as examination gloves, tongue depressors, elastic bandages, and basic surgical drapes).
- Class II (Low-to-Moderate Risk): Low-risk invasive devices, active devices, and basic diagnostics (such as hypodermic needles, urinary catheters, contact lenses, and blood pressure monitors).
- Class III (Moderate-to-High Risk): High-risk invasive and active devices (such as infusion pumps, lung ventilators, bone plates, and clinical diagnostics for infectious diseases).
- Class IV (High Risk / Highest Risk): Implantable devices and life-sustaining equipment (such as cardiac pacemakers, coronary stents, orthopedic joint prostheses, and implantable surgical mesh).
Volume and Composition of the Ghana FDA Device Registry
Our database analysis of the Ghana FDA products register extract dated June 22, 2026, isolates the medical device and IVD footprint. Out of 17,097 total registered products in the database (which includes foods, drugs, cosmetics, and household chemicals), we isolated a subset of 267 active medical device and IVD records.
This subset was identified using the FDA's designated category markers: Non-Invasive, NON-INVASIVE DEVICE, NON-INVASIVE, INVASIVE DEVICE, INVASIVE, IN-VITRO DIAGNOSTIC, IVD, IN-VITRO DIAGNOSTIC TEST, Active Device, SINGLE-USE DEVICE, IN-VITRO DIAGNOSTIC DEVICE, and Software as a Medical Device (SaMD).
The composition of the Ghana FDA registry is detailed below:
- Class I (Low Risk): 148 registrations (55.43% of devices)
- Class II (Moderate Risk): 92 registrations (34.46% of devices)
- Class III (High Risk): 17 registrations (6.37% of devices)
- Class IV (Highest Risk): 10 registrations (3.75% of devices)
- Total Registered Medical Devices: 267 listings (100.00%)
This risk distribution reveals that Class I and Class II devices account for 89.89% of all active registrations. This reflects the high volume of basic clinical consumables, diagnostics, and personal protective equipment registered in Ghana. The low volume of Class III and Class IV devices (10.11% combined) indicates that high-risk active implants and life-supporting equipment are registered under fewer, highly consolidated listings, or that manufacturers of high-risk hardware undergo a longer evaluation cycle.
Analysis of Class I Listings
Class I registrations dominate the Ghana FDA registry. These listings represent high-volume, low-risk consumables used across primary health care. Typical entries include non-sterile exam gloves, cotton wool rolls, gauze bandages, surgical paper tape, and basic diagnostic accessories. Because Class I devices do not undergo intensive clinical trials or physical site inspections, their registration is fast (often 3 to 4 months) and inexpensive (~$1,000 USD), making it an easy entry point for foreign manufacturers testing the West African market.
Analysis of Class II Listings
Class II devices represent the second largest segment, representing low-to-moderate risk hardware and diagnostic systems. These include sterile surgical sutures, hypodermic syringes with needles, blood pressure cuffs, clinical thermometers, dental restorative materials, and diagnostic reagents (excluding high-risk blood transfusion screening kits). Registration of Class II devices requires more robust quality documentation, including ISO 13485 certification and proof of electrical safety compliance under IEC 60601 standards for active hardware.
Analysis of Class III and Class IV Listings
Class III (6.37%) and Class IV (3.75%) devices represent a small fraction of the database. These are critical, high-risk systems:
- Class III items registered in Ghana include central venous catheters, hemodialysis tubing, ventilator accessories, and rapid diagnostic test kits for infectious diseases (like HIV, Malaria, and Hepatitis).
- Class IV items represent life-supporting implantable hardware, such as coronary drug-eluting stents, pacemakers, and orthopedic hip/knee joint prostheses.
The low volume of high-risk listings is due to the intense regulatory barrier. Class III and Class IV applications require the submission of clinical trial data, stability testing logs, and are subject to mandatory laboratory evaluation by the Ghana FDA Quality Control Laboratory. Furthermore, their registration fees are significantly higher ($2,500 to $3,000 USD), discouraging speculative registrations.
Countries of Origin: China and India Lead the Ghanaian Market
Analyzing the country of origin (country_origin) for registered medical devices in Ghana provides a clear picture of the export nations supplying the market:
| Rank | Country of Origin | Number of Active Registrations | Percentage of Device Registry | Primary Product Categories |
|---|---|---|---|---|
| 1 | CHINA | 131 | 49.06% | Examination gloves, syringes, surgical gowns, rapid diagnostic test kits |
| 2 | INDIA | 40 | 14.98% | Surgical sutures, trauma implants, basic clinical consumables |
| 3 | UNITED KINGDOM | 26 | 9.74% | Professional diagnostic reagents, clinical chemistry controls, hygiene packs |
| 4 | TURKEY | 13 | 4.87% | Orthopedic consumables, sterile drapes, hospital textiles |
| 5 | GERMANY | 8 | 3.00% | High-end surgical instruments, diagnostic hardware, optics |
| 6 | JAPAN | 8 | 3.00% | Patient monitoring systems, clinical ultrasound equipment |
| 7 | USA | 5 | 1.87% | Specialized molecular diagnostics, advanced active hardware |
| 8 | MEXICO | 5 | 1.87% | Catheters, generic medical tubing |
| 9 | EGYPT | 4 | 1.50% | Basic medical packaging, wound care |
| 10 | ISRAEL | 4 | 1.50% | Advanced diagnostic software, clinical sensors |
Ghana FDA Medical Device Country of Origin Share (Top 5):
China: [========================================] 49.06%
India: [============] 14.98%
UK: [========] 9.74%
Turkey: [====] 4.87%
Germany: [==] 3.00%
The Chinese Lead (49.06%)
China is the leading country of origin for medical devices in Ghana, supplying 131 registrations (49.06%). This high concentration is driven by the demand for low-cost, high-volume consumables. Chinese manufacturers supply the vast majority of surgical gloves, sterile syringes, needles, and personal protective equipment used in Ghanaian public hospitals.
The Indian Footprint (14.98%)
India represents the second largest exporter, holding 40 registrations (14.98%). Indian registrations are concentrated in surgical sutures, basic wound care, and orthopedic trauma consumables.
The United Kingdom's Channel (9.74%)
The United Kingdom holds a strong position with 26 registrations (9.74%). This is driven by historical colonial links and established trade channels between British healthcare suppliers and Ghanaian pharmaceutical firms. As analyzed in the local agent section, a major portion of these UK registrations is represented by a single local distributor.
The Leading Local Agents and Applicant Dynamics
To register products in Ghana, foreign manufacturers must partner with a licensed local representative. Similar to other West African markets, a handful of local agents hold the majority of registered listings, representing a concentrated channel:
| Rank | Local Agent Name | Number of Active Registrations | Percentage of Device Registry | Key Manufacturers Represented |
|---|---|---|---|---|
| 1 | Mokat Chemists Limited | 24 | 8.99% | Fortuna Healthcare (United Kingdom) |
| 2 | Costless Ventures | 21 | 7.87% | Various Chinese consumable manufacturers |
| 3 | Gokals Limited | 12 | 4.49% | Global diagnostic and ophthalmic brands |
| 4 | BD (West Africa) Limited | 10 | 3.75% | Becton Dickinson (USA/Global) |
| 5 | Phyllyps Medical Diagnostic Company | 6 | 2.25% | Point-of-care IVD manufacturers |
| 6 | MTV Marketing | 6 | 2.25% | Low-risk clinical hardware brands |
| 7 | UNICOM CHEMIST LIMITED | 5 | 1.87% | General clinical consumables, pharmaceuticals |
| 8 | Lucky Development Co. Ltd. | 5 | 1.87% | Asian healthcare consumables |
| 9 | Moon Pharma Ghana Limited | 4 | 1.50% | Rapid diagnostics, generic consumables |
| 10 | Maxmed Enterprise | 4 | 1.50% | Surgical and wound care suppliers |
Ghana Top Local Agent Holdings:
Mokat Chemists: [========================] 24
Costless Ventures: [=====================] 21
Gokals Limited: [============] 12
BD West Africa: [==========] 10
Phyllyps Medical: [======] 6
Mokat Chemists Limited: The UK Connection
Mokat Chemists Limited is the top local agent in Ghana, holding 24 registrations (8.99% of the database). An inspection of their portfolio reveals a highly focused channel relationship: all 24 of their registrations are manufactured by Fortuna Healthcare, based in London, United Kingdom. Fortuna specializes in home healthcare diagnostics, personal care products, and professional clinical consumables. Mokat Chemists serves as their exclusive regulatory and commercial gatekeeper in Ghana.
Costless Ventures: Consumable Pipeline
Costless Ventures holds 21 registrations (7.87%). Costless specializes in importing and distributing high-volume sterile consumables (gloves, syringes, infusion sets) sourced from various Chinese manufacturers.
Gokals Limited and BD (West Africa)
- Gokals Limited (12 registrations) is an established distributor of diagnostic systems and ophthalmic products.
- BD (West Africa) Limited (10 registrations) acts as the direct local subsidiary for Becton Dickinson, managing the registration of BD's specialized blood collection systems, needles, and clinical diagnostics.
Chronological Trends in FDA Registrations
Analyzing the approval dates of active medical devices in the Ghana FDA database reveals a clear peak:
- 2024 Registrations: 76 records (28.46%)
- 2025 Registrations: 190 records (71.16%)
- 2026 Registrations: 1 record (0.37% - reflecting early-year database entries)
- Total Active Registrations: 267 records (100.00%)
This registration distribution demonstrates that 71.16% of the active database was registered in 2025. This concentration is attributed to a major modernization and digitization push by the Ghana FDA.
In 2024, the FDA transitioned its registration tracking to the VerifyPermit portal, introducing strict electronic verification of registration certificates. This forced local distributors and foreign manufacturers to undergo re-registration of their active product lines to ensure their listings appeared in the public VerifyPermit portal, resulting in the 2025 peak.
Step-by-Step Pathway to Ghana FDA Registration
Foreign manufacturers and their local representatives must execute a structured regulatory pathway to secure registration with the Ghana FDA:
[Phase 1: Appoint Local Agent]
Appoint a licensed Ghanaian Distributor as Local Agent
Execute formal Power of Attorney (PoA)
↓
[Phase 2: Technical Dossier Compilation]
Compile technical file in GHTF format (English)
Provide Certificate of Free Sale (CFS) from country of origin
Ensure labeling meets prominent English requirements
↓
[Phase 3: Administrative Submission]
Local Agent uploads dossier via VerifyPermit Portal
Pay evaluation fees (varies by class, approx. $1,000 - $3,000 USD)
↓
[Phase 4: Laboratory Sample Analysis]
Ship product samples to FDA Central Laboratory (Accra)
Pass quality, sterility, and performance verification
↓
[Phase 5: Technical QMS Audit (Desk Review)]
Submit ISO 13485 certificate and MDSAP report for Desk Review
↓
[Phase 6: Committee Review & License Issuance]
Presentation to the FDA Medical Device Committee
Issue Registration Certificate (Valid for 3 Years)
Step 1: Appoint the Local Agent
The foreign manufacturer must issue a formal Power of Attorney (PoA) authorizing a licensed Ghanaian importer/wholesaler to act as their Local Agent. The PoA must be notarized in the country of origin.
Step 2: Compile the Technical Dossier
The technical file must be submitted in English. Key requirements include:
- Administrative documents: Power of Attorney, valid Wholesale/Facility License of the local agent, and a legalized Certificate of Free Sale (CFS) from the country of origin.
- Device specifications: Detailed description of the device, raw materials, clinical indications, and manufacturing flowcharts.
- Quality Management: A valid ISO 13485 certificate. For manufacturers using the Medical Device Single Audit Program, the MDSAP report can be submitted to secure a QMS audit waiver.
- Labeling: Packaging layouts, labeling inserts, and Instructions for Use (IFU) must be in English.
Step 3: Portal Submission and Fees
The local representative uploads the dossier to the Ghana FDA portal and pays the registration fee. The official fees for imported medical devices are structured as follows:
- Class A / Class I: ~$1,000 USD equivalent (payable in GHS)
- Class B / Class II: ~$1,500 USD equivalent
- Class C / Class III: ~$2,500 USD equivalent
- Class D / Class IV: ~$3,000 USD equivalent
Ghana FDA registrations are valid for three years for imported devices (local manufacturers receive a 5-year validity).
Step 4: Laboratory Sample Testing
The manufacturer must ship physical product samples to the Ghana FDA Quality Control Laboratory (QCL) in Accra. The QCL performs visual, physical, chemical, and microbiological testing to verify that the device matches its technical specifications. For sterile devices, sterility testing is mandatory and requires a incubation period of up to 14 days. For specific in vitro diagnostic (IVD) rapid test kits (such as HIV, malaria, or hepatitis tests), clinical evaluation testing is conducted using national panel reference samples to verify diagnostic sensitivity and specificity.
Step 5: Good Manufacturing Practice (GMP) Facility Audit or Desk Review
To ensure manufacturing quality, the Ghana FDA requires all foreign production sites to undergo a QMS audit. Foreign manufacturers can request a Desk Review (audit waiver) by submitting their latest ISO 13485 certificate, a Certificate of Free Sale (CFS), and a comprehensive audit report from a recognized regulatory body. Submitting a Medical Device Single Audit Program (MDSAP) report or an FDA Establishment Inspection Report (EIR) is the most effective way to secure this waiver, avoiding the travel costs and scheduling backlogs of a physical inspection.
Step 6: Technical Committee Evaluation and Board Approval
Once the laboratory tests, technical dossier review, and QMS Desk Review are successfully completed, the application is presented to the FDA Medical Device Technical Committee. The committee meets quarterly to evaluate applications and issue recommendations to the FDA Governing Board. Upon final board approval, the FDA issues a Registration Certificate containing a unique registration number (e.g., FDA/MD/Class-X/YYYY/ZZ), and the product is listed as active in the VerifyPermit database.
Regional Comparison: West African Regulatory Metrics
Understanding how Ghana's regulatory requirements compare with neighboring Nigeria is essential for manufacturers planning a West African expansion strategy:
| Parameter | Ghana (FDA) | Nigeria (NAFDAC) |
|---|---|---|
| National Regulator | Food and Drugs Authority, Ghana | National Agency for Food and Drug Admin |
| Registration Validity | 3 Years (Imported), 5 Years (Local) | 5 Years |
| Dossier Format | GHTF Technical Dossier (English) | GHTF Technical File (English) |
| Mandatory Lab Testing | Selective (Based on product class) | Mandatory (Required for almost all classes) |
| QMS Audit Requirement | Mandatory (Desk Review waivers accepted) | Mandatory (Desk Review waivers accepted) |
| Average Registration Timeline | 4 to 8 Months | 6 to 12 Months |
| Public Database | VerifyPermit Portal (Public) | Greenbook Portal (Public) |
| Late Renewal Penalties | Flat late fee per month | High late renewal fee + re-registration risk |
Ghana offers a slightly shorter registration timeline and more selective laboratory testing compared to Nigeria, but the registration is valid for only 3 years for imported products, compared to Nigeria's 5 years, necessitating a more frequent renewal cycle.
Strategic Takeaways for Medtech Exporters
- Plan for the Renewal Cycle: Imported-device registrations are commonly understood to be valid for about three years (confirm the current validity rule against the FDA guideline, FDA/MCH/MDD/GL-RMD/2013/01). If that rule holds, the fact that 71.16% of the active database was registered in 2025 points to a concentrated renewal wave around 2028. Manufacturers should prepare renewal dossiers roughly a year ahead to avoid customs clearance delays.
- Leverage MDSAP for Desk Review Waivers: Ghana FDA requires proof of manufacturing facility compliance. To avoid the high cost and long delay of a physical inspection by Ghanaian auditors, manufacturers should submit a valid MDSAP audit report to qualify for a Desk Review waiver.
- Appoint Local Agents Wisely: Securing a partner like Mokat Chemists or Gokals who has an established wholesale license and experience navigating the VerifyPermit portal is critical. Ensure your agreement allows for registration transfer if commercial targets are not met.
- Confirm Portal Listings: Regularly check that your devices appear as "Active" on the VerifyPermit portal. If a listing is missing or marked inactive, customs clearance will be blocked at Tema Port or Accra Airport.
Frequently Asked Questions (FAQs)
How does the Ghana FDA classify medical devices by risk?
Ghana FDA classifies devices into four risk categories: Class I (Low Risk), Class II (Low-to-Moderate Risk), Class III (Moderate-to-High Risk), and Class IV (High Risk). This classification determines the dossier requirements, evaluation fees, and audit protocols.
Which local agent holds the most medical device registrations in Ghana?
Mokat Chemists Limited holds the most registrations with 24 active listings, acting as the exclusive local representative for UK-based Fortuna Healthcare.
How long is a medical device registration valid in Ghana for imported products?
For imported products, a Ghana FDA registration is valid for exactly three years. For locally manufactured products, the registration is valid for five years.
What are the language requirements for Ghana FDA dossiers?
All registration applications, technical files, labeling, inserts, and instructions for use (IFU) must be submitted in English.
Does Ghana FDA require physical inspection of foreign manufacturing facilities?
Yes, the FDA mandates a QMS compliance audit of the manufacturing site. However, the FDA routinely accepts a Desk Review waiver if the manufacturer submits a valid ISO 13485 certificate along with a recent MDSAP audit report or a reference regulator inspection report (e.g., US FDA EIR).
Sources and Database Metadata
- Primary Dataset: Ghana FDA VerifyPermit Search Portal:
https://verifypermit.fdaghana.gov.gh/publicsearch - Official Regulator Website: Ghana FDA Guidelines for Medical Devices:
https://fdaghana.gov.gh/product-register/ - Enactment Text: Ghana Public Health Act, 2012 (Act 851).
- Analysis Extract Date: June 22, 2026.
- Total Analyzed Sample: 267 active medical device and IVD records.
Disclaimer: The statistical data, classifications, and regulatory insights presented in this analysis are derived from the Ghana FDA VerifyPermit public database extract dated June 22, 2026. They are intended for educational and strategic planning purposes only. Foreign manufacturers must verify current registration fees, dossier formats, laboratory sample volumes, and GMP audit protocols directly with the Ghana FDA or their appointed local representatives in Accra before making commercial decisions.